Medera’s Sardocor Announces FDA Clearance of Investigational New Drug Application and Initiation of First-In-Human Gene Therapy Clinical Trial for Heart Failure with Preserved Ejection Fraction (HFpEF)

Sarcodor is a subsidiary fully owned by Medera Medera’s Sardocor Announces FDA Clearance of Investigational New Drug Application and Initiation of First-In-Human Gene Therapy Clinical Trial for Heart Failure with Preserved Ejection Fraction (HFpEF) Heart failure is a...